Related Experiment Videos
Cerebrovascular Disease in Pregnancy
Salina Waddy1, Barney J. Stern
1Department of Neurology.
Current Treatment Options in Cardiovascular Medicine
|June 5, 2003
Summary
Diagnosing cerebrovascular disease in pregnancy is challenging. Treatment for pregnant patients with stroke involves antithrombotic agents, with specific recommendations for cryptogenic or identified etiologies, and cautious use of warfarin.
Area of Science:
- Neurology
- Obstetrics
- Hematology
Background:
- Cerebrovascular disease during pregnancy presents diagnostic and therapeutic challenges.
- Fetal toxicity from diagnostic tests and treatments is a significant concern.
- Identifying the precise cause of stroke in pregnant individuals is crucial for effective management.
Purpose of the Study:
- To outline evidence-based therapeutic strategies for cerebrovascular events in pregnancy.
- To provide guidance on anticoagulant selection and timing during pregnancy.
Main Methods:
- Review of current literature and clinical guidelines for managing stroke in pregnancy.
- Analysis of anticoagulant properties and safety profiles relevant to obstetric patients.
Main Results:
- For cryptogenic arterial ischemic events, low-dose aspirin or other antithrombotics are recommended.
- Specific etiologies warrant unfractionated heparin or low molecular weight heparin.
- Warfarin use is restricted to specific situations (e.g., heparin-induced thrombocytopenia) and limited to the second and third trimesters, post-organogenesis.
Conclusions:
- Tailored anticoagulant therapy is essential for managing cerebrovascular disease in pregnancy.
- Anticoagulant choice depends on the stroke's etiology and gestational stage.
- Alternating heparin and warfarin regimens are generally impractical due to difficulties in maintaining consistent anticoagulation.